AbbVie Inc.
AbbVie profile: $61.2B FY2025 revenue, Abbott spin-off history, CEO Robert A. Michael, Skyrizi, Rinvoq, Humira, Botox, and rivals.
Curated Industry List
Top Pharmaceuticals
in USA
Sector Depth
4
USA has established itself as a critical hub for Pharmaceuticals innovation. The following list highlights the dominant market players currently headquartered or primarily operating within the USA region, sorted by overall market impact and revenue scale heading into 2026.
Pharmaceuticals Leaderboard: USA
Amgen Inc.
Amgen history, FY2025 revenue, CEO Robert Bradway, biologics, Horizon medicines, biosimilars, obesity pipeline, and risks.
Regeneron Pharmaceuticals, Inc.
Regeneron profile covering FY2025 revenue, Leonard Schleifer, EYLEA, Dupixent, acquisitions, DB-OTO status, and biotech strategy.
Moderna, Inc.
Moderna, Inc. reported FY2025 revenue of $1.944B. See its business model, history, leadership, competitors, and latest annual filing data.
Strategy Note
The Pharmaceuticals sector in USA is characterized by high strategic focus and niche dominance. Companies in this region often benefit from local regulatory frameworks and accessible talent pools specific to USA.
Analysis Status100% Data Coverage
Market OutlookGrowth Projection: Strong
Frequently Asked Questions
Who is the biggest Pharmaceuticals company in USA?
Currently, AbbVie Inc. holds the top position in USA within the Pharmaceuticals sector, based on reported revenue and market valuation.
How competitive is Pharmaceuticals in USA?
With 4 major players analyzed, the Pharmaceuticals market in USA shows a concentrated landscape.